ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 084,11
-0,10%
Dow Jones
39 391,61
-0,70%
DAX
18 649,68
-0,17%
Brent Oil
81,47
-0,07%
Bitcoin
68 099,25
-1,45%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Labcorp Holdings Inc (LH)

  7. Labcorp Holdings Inc (LH) Actualités

LH

Labcorp (LH)

Labcorp Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:LH
DateHeureSourceTitreSymboleSociété
17/05/202422h57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LHLabcorp Holdings Inc
17/05/202422h45Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:LHLabcorp Holdings Inc
17/05/202422h41Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNYSE:LHLabcorp Holdings Inc
17/05/202422h32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
17/05/202422h10Edgar (US Regulatory)Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)NYSE:LHLabcorp Holdings Inc
16/05/202422h19Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
16/05/202414h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
15/05/202414h00PR Newswire (US)Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during PregnancyNYSE:LHLabcorp Holdings Inc
14/05/202418h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLabcorp Holdings Inc
08/05/202412h59PR Newswire (US)Labcorp to Webcast Its Annual Meeting of ShareholdersNYSE:LHLabcorp Holdings Inc
07/05/202422h05PR Newswire (US)Invitae Receives Court Approval for Sale to LabcorpNYSE:LHLabcorp Holdings Inc
06/05/202422h40Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNYSE:LHLabcorp Holdings Inc
29/04/202413h00PR Newswire (US)Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BNYSE:LHLabcorp Holdings Inc
25/04/202412h58PR Newswire (US)Labcorp Announces 2024 First Quarter ResultsNYSE:LHLabcorp Holdings Inc
25/04/202403h27PR Newswire (US)Labcorp Announces Winning Bid for Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
25/04/202403h19PR Newswire (US)Invitae Enters into Agreement with Labcorp for Sale of BusinessNYSE:LHLabcorp Holdings Inc
15/04/202413h00PR Newswire (US)Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood DrawNYSE:LHLabcorp Holdings Inc
11/04/202412h59PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
10/04/202412h49PR Newswire (US)Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection KitNYSE:LHLabcorp Holdings Inc
08/04/202413h00PR Newswire (US)Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development ProgramsNYSE:LHLabcorp Holdings Inc
05/04/202413h00PR Newswire (US)Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical ResearchNYSE:LHLabcorp Holdings Inc
02/04/202413h00PR Newswire (US)Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer ResearchNYSE:LHLabcorp Holdings Inc
01/04/202414h00Business WireXcell Biosciences Strengthens Cell and Gene Therapy Collaboration With LabcorpNYSE:LHLabcorp Holdings Inc
29/03/202414h00PR Newswire (US)The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening LabNYSE:LHLabcorp Holdings Inc
28/03/202413h00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNYSE:LHLabcorp Holdings Inc
27/03/202412h00PR Newswire (US)Labcorp to Announce First Quarter Financial Results on April 25, 2024NYSE:LHLabcorp Holdings Inc
20/03/202412h00PR Newswire (US)Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical TrialsNYSE:LHLabcorp Holdings Inc
16/03/202415h29PR Newswire (US)Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian CancerNYSE:LHLabcorp Holdings Inc
07/03/202413h00PR Newswire (US)Labcorp Launches Weight Loss Management Testing SolutionsNYSE:LHLabcorp Holdings Inc
21/02/202414h19GlobeNewswire Inc.Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardNYSE:LHLabcorp Holdings Inc
 Showing the most relevant articles for your search:NYSE:LH

Dernières Valeurs Consultées

EU
DG
Vinci
NASDAQ
AAPL
Apple
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
EU
AF
Air FranceKLM
EU
BEL20
Bel 20
FTSE
UKX
FTSE 100
USI
USTECH100
US Tech 100
EU
MC
Lvmh Moet Hennessy Louis...
SPI
SP500
S&P 500
EU
BNP
BNP Paribas
NYSE
KO
Coca Cola
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés